country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-106197

Copy Link Print Information

T-0902611

T-0902611 is an inhibitor targeting the human cytomegalovirus HCMV helicase‑primase complex. T-0902611 covalently modifies its target components, thereby disrupting complex function and inhibiting HCMV DNA replication. T-0902611 can be used in studies related to human cytomegalovirus infection.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 350595-60-7
Formel: C₁₃H₁₆N₆O₃
Molecular Weight:304.30

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

T-0902611 Chemical Structure

CAS. Nr.: 350595-60-7

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Alle DNA/RNA Synthesis Isoform-spezifische Produkte anzeigen :

In Vitro

T-0902611 is a specific HCMV inhibitor that exerts anti-HCMV activity 30-fold stronger than that of Ganciclovir (HY-13637) in vitro via covalent modification of the primase component of the HCMV helicase/primase complex^[1]^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS. Nr. 350595-60-7
Molecular Weight 304.30
Formel C₁₃H₁₆N₆O₃
SMILES

CC1=C(C(N2C=CN=C2)=NC(N3[C@H](COCC3)C)=N1)[N+]([O-])=O
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Eizuru Y. Development of New Antivirals for Herpesviruses. Antiviral Chemistry and Chemotherapy, 2003,14:299‑308.

[2]. Coen DM, et al. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nature reviews. Drug discovery. 2003 Apr;2(4):278-88. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen